SCHEMBL6734743

SCHEMBL6734743

Nc1cccc(Oc2ccccc2OCc2ccccc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.71
APP P05067 1/20 0.53
MAPT P10636 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MAOA P21397 2/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
GAA P10253 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HTR1A P08908 2/20 0.48
ADRA1D P25100 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48
LTA4H P09960 1/20 0.47
MAPK14 Q16539 1/20 0.47
ABCB1 P08183 1/20 0.46
DRD2 P14416 1/20 0.46
C5AR1 P21730 1/20 0.45
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6735308 0.84 MAOB (0.54) MAOBMAPTL3MBTL1MAPK1TDP1
3-(Benzyloxy)Aniline SCHEMBL291445 0.83 MAOB (1.00) MAOBAPPMAPTL3MBTL1MAOA
3-(Benzyloxy)Aniline SCHEMBL29428912 0.83 MAOB (1.00) MAOBAPPMAPTL3MBTL1MAOA
SCHEMBL7917775 0.83 MAOB (0.80) MAOBMAPTMAOAGAARAB9A
SCHEMBL29929290 0.83 MAOB (0.72) MAOBMAPTMAOAGAARAB9A
SCHEMBL707810 0.83 MAOB (0.72) MAOBMAPTMAOAGAARAB9A
SCHEMBL30744016 0.83 MAOB (0.58) MAOBAPPMAPTL3MBTL1MAOA
SCHEMBL21295357 0.83 MAOB (0.58) MAOBAPPMAPTL3MBTL1MAOA
SCHEMBL6734779 0.82 MAOB (0.68) MAOBAPPMAPTL3MBTL1MAOA
3-(Benzyloxy)Aniline SCHEMBL11263814 0.82 MAOB (0.96) MAOBAPPMAPTL3MBTL1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800651-B2 Potentiators of glutamate receptors ELI LILLY AND COMPANY 2004-10-05 US disclosed
US-20040006114-A1 Potentiators of glutamate receptors ELI LILLY AND COMPANY 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006114-A1 Potentiators of glutamate receptors GRM1, GRIN1, GRM2 MAOB 2349/4885APP 2787/4885MAPT 3885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.